Skip to main content
Clinical Trials/NCT00471731
NCT00471731
Completed
Not Applicable

Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome

National Eye Institute (NEI)1 site in 1 country72 target enrollmentMay 7, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Turner Syndrome
Sponsor
National Eye Institute (NEI)
Enrollment
72
Locations
1
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Premature ovarian failure (POF) is known to be associated with an increased risk of ocular surface disease (dry eye), likely due to the reduction of both estrogens and androgens seen in this condition. From preliminary data, we suspect that women with Turners syndrome (45, XO), a genetic abnormality that affects sex hormone levels, are also at increased risk of ocular surface disease. Comparing POF and TS women may allow us to distinguish different mechanisms for ocular surface disease, due to the different etiologies of hormonal (estrogen and androgen) alterations posed by POF and TS.

Detailed Description

Premature ovarian failure (POF) is known to be associated with an increased risk of ocular surface disease (dry eye), likely due to the reduction of both estrogens and androgens seen in this condition. From preliminary data, we suspect that women with Turners syndrome (45, XO), a genetic abnormality that affects sex hormone levels, are also at increased risk of ocular surface disease. Comparing POF and TS women may allow us to distinguish different mechanisms for ocular surface disease, due to the different etiologies of hormonal (estrogen and androgen) alterations posed by POF and TS.

Registry
clinicaltrials.gov
Start Date
May 7, 2007
End Date
November 13, 2014
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials